Filing Flows › ResMed (RMD) › Gross margin
ResMed (RMD) gross margin by quarter
ResMed's gross margin was 61.5% in Q1 FY27 (first quarter fiscal 2027), +2.7 pts from Q4 FY26. Over the last 7 quarters it ranged from 58.8% (Q4 FY26) to 62.2% (Q3 FY26).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | 61.5% | +2.7 pts | +0.3 pts |
| Q4 FY26 | 58.8% | -3.4 pts | -2.0 pts |
| Q3 FY26 | 62.2% | +0.5 pts | +2.9 pts |
| Q2 FY26 | 61.8% | +0.5 pts | — |
| Q1 FY26 | 61.2% | +0.4 pts | — |
| Q4 FY25 | 60.8% | +1.5 pts | — |
| Q3 FY25 | 59.3% | — | — |
Q1 FY27 at a glance
ResMed, Q1 FY27: revenue $1.4B (+6% year over year), operating margin 32.0%, net earnings $418M, operating cash flow $422M. The chart follows the revenue to costs, profit and cash.
Questions
What is ResMed's gross margin?
ResMed's gross margin was 61.5% in Q1 FY27 (first quarter fiscal 2027), +2.7 pts from Q4 FY26.
How has ResMed's gross margin changed?
Over the last 7 quarters it ranged from 58.8% (Q4 FY26) to 62.2% (Q3 FY26).